» Articles » PMID: 31258705

Correlation Between Serum Transforming Growth Factor β1, Interleukin-6 and Neonatal Respiratory Distress Syndrome

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2019 Jul 2
PMID 31258705
Authors
Affiliations
Soon will be listed here.
Abstract

Trend and correlation of transforming growth factor β1 (TGF-β1) and interleukin-6 (IL-6) in serum of children with neonatal respiratory distress syndrome (NRDS) were investigated. A total of 75 NRDS children born in the Xiangyang Central Hospital from July 2015 to August 2017 were analyzed retrospectively. A total of 45 NRDS premature infants who received pulmonary surfactant (PS) within 12 h after birth were treated as PS group, 30 who did not receive PS treatment as non-PS group, and 32 premature infants without NRDS in the same period were selected as control group. Serum levels of TGF-β1 and IL-6 were detected by enzyme linked immunosorbent assay (ELISA) at various time points after birth and their correlation was analyzed. The expression level of TGF-β1 in serum of children in PS group was significantly higher than that in control group on days 1 and 3 after birth (P<0.05). The expression level of TGF-β1 in non-PS group increased continuously with the increase of number of days and was significantly higher than that in control group on days 1, 3 and 7 after birth (P<0.05), and significantly higher than that in PS group on days 3 and 7 after birth (P<0.05). The analysis of the correlation between the severity of the disease and the expression levels of TGF-β1 and IL-6 showed that the expression levels were elevated with the increase of the disease severity. The expression levels of TGF-β1 and IL-6 were positively correlated with severity of the disease (r=0.7509, P<0.05; r=0.8056, P<0.05). The expression levels of TGF-β1 and IL-6 in PS and non-PS groups were positively correlated (r=0.9042, P<0.05; r=0.8905, P<0.05). The results showed that serum TGF-β1 and IL-6 were elevated in NRDS children, and there was a positive correlation between them.

References
1.
Dhainaut J, Charpentier J, Chiche J . Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome. Crit Care Med. 2003; 31(4 Suppl):S258-64. DOI: 10.1097/01.CCM.0000057901.92381.75. View

2.
Gaede K, Amicosante M, Schurmann M, Fireman E, Saltini C, Muller-Quernheim J . Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease. J Mol Med (Berl). 2005; 83(5):397-405. DOI: 10.1007/s00109-004-0626-0. View

3.
Kinnula V . Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases. Thorax. 2005; 60(8):693-700. PMC: 1747473. DOI: 10.1136/thx.2004.037473. View

4.
Iannuzzi M, Rybicki B . Genetics of sarcoidosis: candidate genes and genome scans. Proc Am Thorac Soc. 2007; 4(1):108-16. PMC: 2647608. DOI: 10.1513/pats.200607-141JG. View

5.
Ma L, Liu C, Wang Y, Li S, Zhai S, Gu X . Mortality of neonatal respiratory failure related to socioeconomic factors in Hebei province of China. Neonatology. 2010; 100(1):14-22. DOI: 10.1159/000320155. View